8-K: The Joint Corp. Reports 2024 Operating Metrics: System-Wide Sales Grow 9%

The Joint Corp. announces its 2024 operating metrics, highlighting a 9% increase in system-wide sales and progress in refranchising its corporate clinic portfolio.

Summary

• The Joint Corp. reported its operating metrics for the year ended December 31, 2024.
• The company saw 14.7 million patient visits, up from 13.6 million in 2023.
• New patients treated totaled 957,000, compared to 932,000 in the previous year.
• System-wide sales increased by 9%, a decrease from the 12% growth in 2023.
• Comp sales remained consistent at 4%, matching the figure from 2023.
• The company sold 46 franchise licenses, down from 55 in 2023.
• The total clinic count expanded to 967, an increase from 935 clinics at the end of 2023.
• The company had 842 franchised clinics and 125 company-owned or managed clinics at the end of 2024.
• The company received letters of intent to refranchise the majority of its corporate clinic portfolio in early January 2025.
• Management intends to report its fourth quarter and year-end 2024 financial results on Thursday, March 13, 2025.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While there's growth in patient visits and clinic count, the slowdown in system-wide sales growth and decrease in franchise sales temper the overall outlook. The company's plans for 2025 and the letters of intent for refranchising provide some optimism.

Positives

• Patient visits increased to 14.7 million in 2024 from 13.6 million in 2023.
• The company expanded its total clinic count to 967 by the end of 2024.
• The company received letters of intent to refranchise the majority of its corporate clinic portfolio in early January 2025.
• The company plans to initiate price increases, strengthen promotions, launch a mobile app, and enhance digital marketing in the first half of 2025.

Negatives

• System-wide sales growth slowed to 9% in 2024, compared to 12% in 2023.
• Franchise license sales decreased to 46 in 2024 from 55 in 2023.
• The number of company-owned or managed clinics decreased to 125 at the end of 2024, compared to 135 at the end of 2023.

Risks

• The company faces risks related to recruiting qualified chiropractors and personnel due to a nationwide labor shortage.
• Inflation could increase costs and negatively impact the business.
• Failure to profitably operate company-owned or managed clinics poses a risk.
• The company's inability to refranchise as planned could impact its strategy.
• Short-selling strategies and negative online opinions could drive down the stock price and lead to lawsuits.
• Failure to remediate material weaknesses in internal control over financial reporting could negatively impact financial reporting accuracy.

Future Outlook

The company plans to transform into a world-class pure-play franchisor in 2025 and will initiate price increases, strengthen promotions, launch a mobile app, and enhance digital marketing in the first half of the year to drive new patient count and improve patient retention.

Management Comments

• Sanjiv Razdan, President and Chief Executive Officer, stated that the team increased patient count, grew comp sales, and expanded franchised clinics in 2024, overcoming challenging macroeconomics.
• Sanjiv Razdan mentioned gathering valuable data to transform The Joint into a world-class pure-play franchisor in 2025 during his first 100-day business immersion.

Industry Context

The Joint Corp. is a key player in the chiropractic industry, utilizing a retail healthcare business model to provide convenient and affordable care. The company's growth in clinic count and patient visits reflects the increasing demand for accessible chiropractic services.

Comparison to Industry Standards

• The Joint Corp.'s franchise model can be compared to other healthcare franchise systems like Massage Envy or Anytime Fitness, which also focus on accessibility and recurring revenue.
• The company's system-wide sales growth of 9% is a key indicator of its performance compared to other franchised healthcare providers.
• The Joint Corp.'s focus on expanding its franchised clinic network aligns with industry trends towards greater accessibility and convenience in healthcare services.

Stakeholder Impact

• Shareholders may be impacted by the company's growth strategy and financial performance.
• Franchisees will be affected by the company's refranchising plans and support initiatives.
• Patients will benefit from increased accessibility and convenience of chiropractic care.
• Employees may experience changes related to the company's transformation into a pure-play franchisor.

Next Steps

• Management intends to report its fourth quarter and year-end 2024 financial results on Thursday, March 13, 2025.
• The company plans to initiate price increases, strengthen promotions, launch a mobile app, and enhance digital marketing in the first half of 2025.
• The company will evaluate options to ensure agreements meet sales and franchise license criteria for refranchising the corporate clinic portfolio.

Key Dates